Concepedia

Mark Dow

MD

Statistics

Publications

13

Citations

423

H-Index

12

Active since

2011

Affiliations

University of Leeds(Current)

Institute of Structural and Molecular Biology

AstraZeneca (United Kingdom)

Max Planck Institute of Molecular Physiology

Lead Discovery Center (Germany)

Mark Dow is an author at University of Leeds specializing in drug discovery, medicinal chemistry, and chemistry.

Publications per year

2011–2023

13

Publications

13

A unified lead-oriented synthesis of over fifty molecular scaffolds

Richard G. Doveston, Paolo Tosatti, Mark Dow et al. · Organic & Biomolecular Chemistry · 2014 · 73 citations · Full text

Natural Sciences, Chemistry, Drug Discovery +3

Towards the systematic exploration of chemical space

Mark Dow, Martin Fisher, Thomas James et al. · Organic & Biomolecular Chemistry · 2011 · 60 citations

Pharmacy, Chemistry, Medicinal Chemistry +17

Morphological subprofile analysis for bioactivity annotation of small molecules

Axel Pahl, Beate Schölermann, Philipp Lampe et al. · Cell chemical biology · 2023 · 43 citations

Pharmacy, Biochemistry, Medicinal Chemistry +15

Single point activation of pyridines enables reductive hydroxymethylation

Bruno Marinič, Hamish B. Hepburn, Alexandru Grozavu et al. · Chemical Science · 2020 · 36 citations · Full text

Natural Sciences, Chemistry, Medicinal Chemistry +14

Evolution of the Dearomative Functionalization of Activated Quinolines and Isoquinolines: Expansion of the Electrophile Scope

Marvin Kischkewitz, Bruno Marinič, Nicolas Kratena et al. · Angewandte Chemie International Edition · 2022 · 33 citations · Full text

Natural Sciences, Chemistry, Catalysis +15

1–5 of 13